In vitro to in vivo translation of effects of phosphodiesterase inhibitors on cardiac contractility

被引:0
|
作者
Liu, Xiaoqin [1 ]
Shaughnessy, Thomas [1 ]
Polakowski, Jim [1 ]
Foley, C. Michael M. [1 ]
机构
[1] AbbVie, N Chicago, IL USA
关键词
D O I
10.1016/j.vascn.2018.01.420
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
046
引用
收藏
页码:124 / 124
页数:1
相关论文
共 50 条
  • [1] Overexpression of sorcin enhances cardiac contractility in vivo and in vitro
    Frank, KF
    Boelck, B
    Ding, Z
    Krause, D
    Brixius, K
    Hajjar, RJ
    Schrader, J
    Schwinger, RH
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 225 - 225
  • [2] Overexpression of sorcin enhances cardiac contractility in vivo and in vitro
    Frank, KF
    Bölck, B
    Ding, Z
    Krause, D
    Hattebuhr, N
    Malik, A
    Brixius, K
    Hajjar, RJ
    Schrader, J
    Schwinger, RHG
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (04) : 607 - 615
  • [3] PHOSPHODIESTERASE INHIBITORS AND MYOCARDIAL-CONTRACTILITY
    VITTONEDECAMILION, L
    CHIAPPEDEMON, LE
    CINGOLANI, HE
    CHIAPPEDECINGOLANI, GE
    ARGEL, MI
    [J]. MEDICINA-BUENOS AIRES, 1978, 38 (06) : 798 - 798
  • [4] Novel Selective Phosphodiesterase Type 1 Inhibitors; a Comprehensive in vitro, ex vivo and in vivo Assessment of Cardiovascular Effects
    Laursen, M.
    Beck, L.
    Bangshaab, M.
    Christoffersen, C. T.
    Bundgaard, C.
    Mogensen, S.
    Hedegaard, E. R.
    Mow, T.
    Grunnet, M.
    Simonsen, U.
    [J]. JOURNAL OF VASCULAR RESEARCH, 2016, 53 : 31 - 31
  • [5] Regional effects of phosphodiesterase-5 (pde5) inhibitors on gastric smooth muscle contractility in vitro.
    Martin, JS
    Thomas, RM
    Ryan, JP
    Parkman, HP
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A548 - A548
  • [6] Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts
    Yuan James Rao
    Lei Xi
    [J]. Acta Pharmacologica Sinica, 2009, 30 : 1 - 24
  • [7] Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts
    Rao, Yuan James
    Xi, Lei
    [J]. ACTA PHARMACOLOGICA SINICA, 2009, 30 (01) : 1 - 24
  • [8] Peroxynitrite and myocardial contractility: In vivo versus in vitro effects
    Katori, Tatsuo
    Donzelli, Sonia
    Tocchetti, Carlo G.
    Miranda, Katrina M.
    Cormaci, Gianfrancesco
    Thomas, Douglas D.
    Ketner, Elizabeth A.
    Lee, Myung Jae
    Maneardi, Daniele
    Wink, David A.
    Kass, David A.
    Paolocci, Nazareno
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (10) : 1606 - 1618
  • [9] Phosphodiesterase inhibitors piroximone and enoximone inhibit platelet aggregation in vivo and in vitro
    Buerke, M
    Cyrus, T
    Darius, H
    [J]. THROMBOSIS RESEARCH, 1997, 88 (02) : 89 - 98
  • [10] Use of an in vitro contractility assay to explore cardiac contractility changes observed in an in vivo cardiovascular study
    Sun, Sunny Z.
    Harris, Peter
    Flynn, Declan
    Steidl-Nichols, Jill
    Fermini, Bernard
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E21 - E21